Lung Adenocarcinoma Recurring Years After Surgery in a Woman With a Separate Rectal Neuroendocrine Tumor

Patient Info: Anonymized, female, 60s | Stage I

She died from progression of lung cancer about 12 years after the lung-cancer diagnosis and 13 years after the earlier rectal neuroendocrine-tumor procedure.

PubMed CentralRead more →

Melissa Eppard: Stage I triple-negative breast cancer survivorship and intimacy recovery story

Patient Info: Melissa Eppard, Female | Stage I

Biomarkers: Triple-negative breast cancer

As of June 2025, Melissa was described as a Stage I triple-negative breast cancer survivor, cancer thriver, coach, and co-founder focused on intimacy, comfort, confidence, and sexual wellness after cancer.

Stage I Gastric Cancer: Sarah's Survivor Story

Patient Info: Sarah Grace Beckham, Under 40 | Stage I

Biomarkers: CDH1 mutation

Five years after the gastrectomy, the patient reported remaining cancer-free and living a normal, active life.

MD AndersonRead more →

Stage IA invasive lobular breast cancer with ipsilateral marginal zone lymphoma: no recurrence after surgery and radiation

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: Breast cancer was ER-positive, PR-negative, HER2-negative. Separate marginal zone lymphoma showed CD20/Bcl-2 markers

As of May 2025, five-month follow-up imaging showed no recurrence of the right breast invasive lobular carcinoma and no clinical recurrence of the ipsilateral marginal zone lymphoma.

PubMed CentralRead more →

Stage I Breast Cancer: Krista's Patient Story

Patient Info: Krista, Female | Stage I

Biomarkers: ATM mutation; hormone receptor-positive; HER2-negative; Oncotype DX score 1

As of May 2025, Krista had undergone double mastectomy with flap reconstruction for Stage IA hormone receptor-positive, HER2-negative breast cancer and was taking tamoxifen with minimal early side effects.

The Patient StoryRead more →

Stage IA ER/PR-positive breast cancer in SLE: arm-behind-back radiation after lumpectomy

Patient Info: Anonymized, Female, 40s | Stage I

Biomarkers: ER >95%; PR >95%; HER2 1+; Ki-67 23%; no BRCA1/2 variants identified

As of April 2025, 15 months after 3D conformal radiotherapy, she had no local recurrence, no distant metastasis, and no radiation pneumonitis.

PubMed CentralRead more →

Stage I Colorectal Cancer: Monica's Survivor Story

Patient Info: Monica Dean, Female, 40s | Stage I

As of April 2025, Monica was disease-free after Stage I colorectal cancer was removed with lower anterior resection; pathology showed clean margins and no lymph node involvement, and she did not need chemotherapy or radiation.

The Patient StoryRead more →

Breast Cancer in a Woman Carrying Both BRCA1 and BRCA2 Mutations

Patient Info: Anonymized, Female | Stage I

Biomarkers: ER-positive, PR-positive, HER2-negative, BRCA1 pathogenic variant, BRCA2 pathogenic variant

Remained free of recurrence 17 months after treatment.

PubMed CentralRead more →

Stage I HR-Positive Invasive Lobular Carcinoma: Mandy's Patient Story

Patient Info: Mandy, Female, 40s | Stage I

Biomarkers: ER-positive; PR-positive; low Oncotype score; genetic testing negative for 70 cancer-causing genes

As of April 2025, Mandy was about 10 months after bilateral mastectomy for Stage IA ER-positive, PR-positive ILC, had a low Oncotype score, was planning several years of tamoxifen, and was still in reconstruction.

Lobular Breast Cancer AllianceRead more →

Early-stage mixed breast carcinoma found during LGI1 limbic encephalitis workup

Patient Info: Anonymized, Female | Stage I

Biomarkers: ER 95-100% positive; PR 80% positive; HER2-negative

She gradually recovered after immunotherapy for limbic encephalitis and excision of the early-stage breast tumor, and had returned to part-time work 12 months after discharge.

PubMed CentralRead more →

Clinical Stage IB lung adenocarcinoma: no recurrence after thoracoscopic lobectomy and pneumatocele repair

Patient Info: Anonymized, Male, 60s | Stage I

Biomarkers: No molecular biomarkers reported; tumor markers were normal: CEA 2.1 ng/mL, SCC antigen 1.5 ng/mL, cytokeratin 19 fragment 0.9 ng/mL

As of March 2025, the patient had no recurrence after thoracoscopic left lower lobectomy for lung adenocarcinoma; postoperative pneumatocele-related air leak resolved with reinforcement and adhesive therapy.

PubMed CentralRead more →

ALK-Fusion Small Cell Lung Cancer Responding to Ensartinib

Patient Info: Anonymized, female, 70+ | Stage I

Biomarkers: EML4-ALK fusion; TP53 and RB1 mutations; PD-L1 at least 50%

The recurrent hilar lymph nodes shrank on ensartinib, and treatment was still ongoing at the January 2025 cutoff with more than 12 months without progression.

PubMed CentralRead more →

Stage I lung adenocarcinoma treated with SBRT while protecting a leadless pacemaker

Patient Info: Anonymized, Female, 70+ | Stage I

SBRT was completed without complications or detected pacemaker malfunction.

PubMed CentralRead more →

Accessory breast cancer: surgery, radiation, endocrine therapy, no recurrence

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: ER 2+/>95%; PR 3+/>95%; HER2-negative; Ki-67 2%

As of March 2025, 26 months after surgery, she continued anastrozole and breast MRI showed no evidence of recurrence.

PubMed CentralRead more →

Early Lung Adenocarcinoma Found During Workup for a Separate Splenic Tumor

Patient Info: Anonymized, male, 60s | Stage I

He remained recurrence-free 24 months after lung surgery and continued CT surveillance every 6 months.

PubMed CentralRead more →

Stage I Lung Cancer: Calvin's Survivor Story

Patient Info: Calvin, Male, Under 40 | Stage I

Calvin completed surgery for Stage I lung cancer, including removal of his entire left lung. As of February 2025, he was adapting to life with one lung and remained focused on family, activity, and self-advocacy.

The Patient StoryRead more →

Stage I Colorectal Cancer: Rashawn's Survivor Story

Patient Info: Rashawn, Female | Stage I

As of January 2025, Rashawn was a 10-year Stage I colorectal cancer survivor after surgery and continued regular screening and proactive health monitoring.

The Patient StoryRead more →

Stage I colon cancer: living 10 years after diagnosis

Patient Info: Rashawn Mitchell, Female, Under 40 | Stage I

Rashawn described reaching 10 years cancer-free after Stage I colon cancer surgery, with ongoing colonoscopy surveillance.

The Patient StoryRead more →

Stage I ER-positive/HER2-positive breast cancer with radiation-associated morphea

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: ER-positive; PR-negative; HER2-positive

No evidence of breast cancer recurrence after 2018 treatment; ongoing issue was generalized morphea and breast deformity related to prior radiation, improved with mycophenolate by April 2024.

PubMed CentralRead more →

Stage IB lung adenocarcinoma: thoracoscopic lobectomy with anomalous pulmonary vein anatomy

Patient Info: Anonymized, Female, 50s | Stage I

Stage IB lung adenocarcinoma was treated with thoracoscopic left lower lobectomy and lymph-node dissection; she recovered uneventfully and was discharged on postoperative day 3.

PubMed CentralRead more →

Stage I Triple-Negative Adenoid Cystic Carcinoma of the Breast

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: Triple-negative

At 6-month follow-up, imaging showed no recurrence or new cancer-related complications.

PubMed CentralRead more →

Stage I triple-negative solid basaloid adenoid cystic breast cancer treated with mastectomy and oral chemotherapy

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: Current tumor was triple-negative with high Ki-67 and c-kit/CK7 staining. Prior breast cancer was ER-positive, HER2-positive, PR-negative.

One year after mastectomy and postoperative tegafur-gimeracil-oteracil potassium, she was recovering well without signs of metastasis.

PubMed CentralRead more →

Stage I lung adenocarcinoma: no recurrence after thoracoscopic lobectomy

Patient Info: Anonymized, Male, 60s | Stage I

No recurrence at 3 months after thoracoscopic right upper lobectomy for pT1cN0M0 lung adenocarcinoma; no additional treatment was needed.

PubMed CentralRead more →

Stage I HR-Positive Invasive Lobular Carcinoma: Janelle's Patient Story

Patient Info: Janelle, Female, 40s | Stage I

Biomarkers: ER-positive; PR-positive; HER2-negative

As of December 2024, Janelle was living with a recent Stage IA ER-positive, PR-positive, HER2-negative lobular carcinoma diagnosis and using her research background to advocate for more inclusive ILC information and studies.

Lobular Breast Cancer AllianceRead more →